Alnylam Pharmaceuticals (ALNY) EBIT Margin (2009 - 2026)
Alnylam Pharmaceuticals (ALNY) recorded EBIT Margin of 17.93% in Q2 2026, up 20.02 percentage points from -2.09% a year earlier but down 5.09 percentage points from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) EBIT Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Alnylam Pharmaceuticals' EBIT Margin came in at 20.81% as of Jun 30, 2026, up 30.31 percentage points year-over-year; for FY2025, it was 13.51%, up 21.37 percentage points from FY2024.
- Annual EBIT Margin has increased for seven straight years, with a five-year change of +181.60 percentage points (FY2020 to FY2025).
- Across earlier years, EBIT Margin came in at -7.87% in FY2024 (+7.57 pp), -15.43% in FY2023 (+60.24 pp), -75.68% in FY2022 (+8.26 pp) and -83.93% in FY2021 (+84.16 pp).
- Quarterly EBIT Margin has ranged from -97.63% in Q3 2022 to 60.26% in Q1 2025 over the past five years.
- On a year-over-year basis, EBIT Margin rose in five of the last eight quarters, with an average year-over-year change of +10.23 percentage points.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 126.12 percentage points in Q3 2023, against a drop of 43.85 percentage points in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at 23.02% (Q1 2026), 12.01% (Q4 2025) and 29.46% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 37.40% |
| 10 | Alnylam Pharmaceuticals | 34.23 Bn | 22.28 Bn | 992.69 Mn | 17.93% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.93% |
| Mar 31, 2026 | 23.02% |
| Dec 31, 2025 | 12.01% |
| Sep 30, 2025 | 29.46% |
| Jun 30, 2025 | -2.09% |
| Dec 31, 2024 | -17.73% |
| Sep 30, 2024 | -15.35% |
| Jun 30, 2024 | 7.37% |
| Mar 31, 2024 | -8.79% |
| Dec 31, 2023 | -26.47% |
| Sep 30, 2023 | 28.50% |
| Jun 30, 2023 | -72.10% |
| Mar 31, 2023 | -46.92% |
| Dec 31, 2022 | -56.30% |
| Sep 30, 2022 | -97.63% |
| Jun 30, 2022 | -85.26% |
| Mar 31, 2022 | -68.80% |
| Dec 31, 2021 | -75.26% |
| Sep 30, 2021 | -96.83% |
| Jun 30, 2021 | -66.27% |
API Access
Alnylam Pharmaceuticals EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();